english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

In-utero exposure to corticosteroids: increased risk of serious infections during the first year of life

Prescrire's review of drug packaging in 2023: reconciling ease of use with safety is an ongoing challenge

Prescrire's contribution to the EMA's consultation on the "Concept Paper for the Development of a Guideline on Non-Inferiority and Equivalence Comparisons in Clinical Trials"

European Commission: lobbyists block nutritional labelling

Dupilumab (Dupixent°) in prurigo nodularis

Netarsudil (Rhokiinsa°) or netarsudil + latanoprost (Roclanda°) in chronic glaucoma: not acceptable

Zanubrutinib (Brukinsa°) in certain haematological malignancies

Methadone: an analysis of adverse effects reported in France

Mediator° trial appeal: a judgement that better reflects the harm done

New data after marketing authorisation: European Commission consultation

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90